Boston Scientific is releasing its Vercise Primary Cell (PC) and Vercise Gevia deep brain stimulation (DBS) systems in the U.S. Both have received recent FDA approval to be used in managing symptoms of Parkinson’s, as well as European regulatory clearance for Parkinson’s, dystonia, and essential tremor.
The devices feature the company& (Read more...)